American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...

U.S. medical device maker Becton Dickinson is considering a potential separation of its life sciences unit at a valuation of ...

BD announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD’s Biosciences and Diagnostic ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of ...

Becton's life sciences division makes diagnostic products such as those used to detect infectious diseases and cancers. Earlier this week, the Financial Times reported activist investor Starboard ...

While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key ...

The plan is to position the New BD as a differentiated MedTech leader and enable optimized investment to accelerate the innovation pipeline and ongoing margin enhancement through BD Excellence to ...

Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports ...

The press release statement serves as the source of the reported facts. In other recent news, Becton Dickinson (BD), a global medical technology firm, has announced a quarterly dividend and the ...

Learn more about whether Becton, Dickinson and Company or Intuitive Surgical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.